Pular para o conteúdo
Merck
  • Subnormothermic ex vivo liver perfusion reduces endothelial cell and bile duct injury after donation after cardiac death pig liver transplantation.

Subnormothermic ex vivo liver perfusion reduces endothelial cell and bile duct injury after donation after cardiac death pig liver transplantation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2014-09-03)
Jan M Knaak, Vinzent N Spetzler, Nicolas Goldaracena, Markus U Boehnert, Fateh Bazerbachi, Kristine S Louis, Oyedele A Adeyi, Leonid Minkovich, Paul M Yip, Shaf Keshavjee, Gary A Levy, David R Grant, Nazia Selzner, Markus Selzner
RESUMO

An ischemic-type biliary stricture (ITBS) is a common feature after liver transplantation using donation after cardiac death (DCD) grafts. We compared sequential subnormothermic ex vivo liver perfusion (SNEVLP; 33°C) with cold storage (CS) for the prevention of ITBS in DCD liver grafts in pig liver transplantation (n = 5 for each group). Liver grafts were stored for 10 hours at 4°C (CS) or preserved with combined 7-hour CS and 3-hour SNEVLP. Parameters of hepatocyte [aspartate aminotransferase (AST), international normalized ratio (INR), factor V, and caspase 3 immunohistochemistry], endothelial cell (EC; CD31 immunohistochemistry and hyaluronic acid), and biliary injury and function [alkaline phosphatase (ALP), total bilirubin, and bile lactate dehydrogenase (LDH)] were determined. Long-term survival (7 days) after transplantation was similar between the SNEVLP and CS groups (60% versus 40%, P = 0.13). No difference was observed between SNEVLP- and CS-treated animals with respect to the peak of serum INR, factor V, or AST levels within 24 hours. CD31 staining 8 hours after transplantation demonstrated intact EC lining in SNEVLP-treated livers (7.3 × 10(-4) ± 2.6 × 10(-4) cells/μm(2)) but not in CS-treated livers (3.7 × 10(-4) ± 1.3 × 10(-4) cells/μm(2) , P = 0.03). Posttransplant SNEVLP animals had decreased serum ALP and serum bilirubin levels in comparison with CS animals. In addition, LDH in bile fluid was lower in SNEVLP pigs versus CS pigs (14 ± 10 versus 60 ± 18 μmol/L, P = 0.02). Bile duct histology revealed severe bile duct necrosis in 3 of 5 animals in the CS group but none in the SNEVLP group (P = 0.03). Sequential SNEVLP preservation of DCD grafts reduces bile duct and EC injury after liver transplantation.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Cloreto de potássio, ACS reagent, 99.0-100.5%
Sigma-Aldrich
Bicarbonato de sódio, ACS reagent, ≥99.7%
Sigma-Aldrich
Bicarbonato de sódio, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Bicarbonato de sódio, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
N-Acetyl-L-cysteine, suitable for cell culture, BioReagent
Sigma-Aldrich
Cloreto de potássio, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Cloreto de potássio, Molecular Biology, ≥99.0%
Sigma-Aldrich
N-Acetyl-L-cysteine, Sigma Grade, ≥99% (TLC), powder
Sigma-Aldrich
Cloreto de potássio, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.0%
Sigma-Aldrich
Cloreto de potássio, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E508, 99-100.5% (AT), ≤0.0001% Al
Sigma-Aldrich
Cloreto de potássio, puriss. p.a., ≥99.5% (AT)
Sigma-Aldrich
Bicarbonato de sódio, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.7%
Sigma-Aldrich
Bicarbonato de sódio, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
Cloreto de potássio, BioUltra, Molecular Biology, ~1 M in H2O
Supelco
Potassium chloride solution, ~3 M KCl, saturated with silver chloride
Sigma-Aldrich
Cloreto de potássio, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Metronidazole, BioXtra
Sigma-Aldrich
Cloreto de potássio, BioXtra, ≥99.0%
Sigma-Aldrich
Bicarbonato de sódio, BioXtra, 99.5-100.5%
Supelco
Cloreto de potássio, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Metronidazole, analytical standard
Sigma-Aldrich
Cloreto de potássio, 99.999% trace metals basis
Supelco
N-Acetyl-L-cysteine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
N-Acetyl-L-cysteine, BioXtra, ≥99% (TLC)
Supelco
Metronidazole, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Cloreto de potássio, BioUltra, Molecular Biology, ≥99.5% (AT)
Supelco
Cloreto de potássio, BioUltra, ~3 M in H2O
Sigma-Aldrich
Cloreto de potássio, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
Sigma-Aldrich
Bicarbonato de sódio, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Cloreto de potássio, 0.075 M, sterile-filtered, BioXtra, suitable for cell culture